sur Zomedica Corp. (NASDAQ:ZOM)
Zomedica Expands Equine Distribution Partnership with Grovet in Europe
Zomedica Corp., a veterinary health company, has announced an expansion of its distribution agreement with Grovet in Europe. This move grants Grovet the exclusive distribution rights for Zomedica's PulseVet® and TRUFORMA product platforms across 27 European countries, including major markets like Germany, France, and Spain. In Italy and the UK, these rights are non-exclusive.
This development will allow the introduction of the TRUFORMA equine platform in Europe, complementing the existing PulseVet offerings. The updated agreement also includes potential future products, such as assays for eACTH and Cortisol, beneficial for diagnosing common equine conditions.
Kevin Klass from Zomedica highlighted Grovet's reliability as a partner, while Grovet's Koen Schmitz emphasized the scientific foundation of Zomedica's products. This partnership aims to enhance the company's presence in the European equine healthcare market.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Zomedica Corp.